Jieying Zhu

Dr. Jieying Zhu

Guangzhou Institutes of Biomedicine and Health, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
ZLZhuo Li
Zhuo Li
ZSZhaoying Shi
Zhaoying Shi
NFNana Fan
Nana Fan
YCYongqiang Chen
Yongqiang Chen
JGJing Guo
Jing Guo
DPDuanqing Pei
Duanqing Pei
CRISPR/Cpf1 system is a novel genomic editing tool. Because of its more sophisticated components, and lower off-target rate, it has the potential to become a better gene-editing tool. Previous reports showed that CRISPR/Cpf1 could work effectively in multiple species. But our data show that AsCpf1 activity has a big difference in different vertebrates. Using in vitro experiments, we finally learned that the difference between species is due to temperature.

22 September 2025 in PNAS Nexus
Verified
Journal Article
Open access
YYYuxiang Yao
Yuxiang Yao
JZJieying Zhu
Jieying Zhu
WLWenfei Li
Wenfei Li
DPDuanqing Pei
Duanqing Pei
The cell fate transition is a fundamental characteristic of living organisms. By introducing external perturbations, it is possible to artificially intervene in cell fate and trigger cell reprogramming. Revealing the general principle underlying the induced phenotypic reshaping of cell populations remains a central focus in the field of cell biology. In this study, we investigate the energetic and dynamic features of induced cell phenotypic transition from differentiated somatic state to pluripotent state by constructing a Boolean genetic network model. The simulation and experimental results highlight the critical role of genetic frustration in initiating cell fate transitions, although the two ending phenotypic states are typically featured by minimal frustration. In addition, the altered gene expression profiles exhibit a scale-free distribution, suggesting that there exist a small number of critical genes responsible for the cell fate transition. This study provides important insights into the dynamic principles governing effective cell reprogramming caused by artificial or exogenous interventions.

5 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
YYYuxiang Yao
Yuxiang Yao
JZJieying Zhu
Jieying Zhu
WLWenfei Li
Wenfei Li
DPDuanqing Pei
Duanqing Pei
The cell fate transition is a fundamental characteristic of living organisms. By introducing external perturbations, it is possible to artificially intervene in cell fate and trigger cell reprogramming. Revealing the general principle underlying the induced phenotypic reshaping of cell populations remains a central focus in the field of cell biology. In this study, we investigate the energetic and dynamic features of induced cell phenotypic transition from differentiated somatic state to pluripotent state by constructing a Boolean genetic network model. The simulation and experimental results highlight the critical role of genetic frustration in initiating cell fate transitions, although the two ending phenotypic states are typically featured by minimal frustration. In addition, the altered gene expression profiles exhibit a scale-free distribution, suggesting that there exist a small number of critical genes responsible for the cell fate transition. This study provides important insights into the dynamic principles governing effective cell reprogramming caused by artificial or exogenous interventions.

20 March 2022 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Verified
Journal Article
Closed access
JZJieying Zhu
Jieying Zhu
DPDuanqing Pei
Duanqing Pei
Liver is one of the most important organs in the human body. Liver diseases are also a major threat to human health and longevity. Hepatic decompensation treatment is quite difficult due to multiple reasons. Extracorporeal liver support devices are unable to solve this problem, and there is a severe shortage of orthotopic liver transplant donors. Study of pluripotent stem cell-derived hepatocytes and organoids can determine not only hepatocyte fate, but also liver development, regeneration mechanisms, and pathophysiology. Furthermore, it can be used for drug screening in order to provide a stable source of functional hepatocytes for future transplantation therapy. Culture of pluripotent stem cell-derived hepatocytes and organoids has a self-organizing process similar to liver development, i.e., starting with changes in several key factors, and eventually forming functionally complex cells/organs. This paper introduces the main methods and progress of pluripotent stem cell-derived hepatocytes and organoids, with hope to provide clues for future research.